Updated Jan 2026
What is 64CU dotatate
It’s a high‑resolution PET tracer for imaging somatostatin‑receptor–positive neuroendocrine tumours (NETs), offering better lesion detection, longer imaging windows, and lower positron energy than 68Ga‑labelled agents. It consistently produces high tumour‑to‑background contrast and often finds additional metastatic sites missed by older SPECT agents like 111In‑octreotide.
🧬 64Cu‑DOTATATE vs 68Ga‑DOTATATE
A clear, patient‑friendly comparison
Both scans are excellent for finding neuroendocrine tumours (NETs). They work in the same basic way: a tracer attaches to somatostatin receptors on NET cells, and a PET/CT scanner shows where those cells are.
The differences mainly relate to image clarity, timing, and practical convenience.
🎯 What this means for patients
1. Image quality
64Cu‑DOTATATE often produces sharper, higher‑contrast images, especially for small lesions or areas with background activity (e.g., liver). 68Ga‑DOTATATE is still excellent, but the shorter half‑life means the tracer fades faster.
Why this matters: Sharper images can help your team see more detail, especially in complex cases.
2. Timing flexibility
Because 64Cu lasts longer in the body, imaging can be done over a wider time window. This reduces stress around exact timing and allows centres to run smoother schedules. 68Ga requires imaging quite soon after injection, which can feel more rushed.
3. Lesion detection
Studies show 64Cu‑DOTATATE can detect additional lesions that 68Ga or older SPECT scans may miss. This is especially true for:
- very small lesions
- liver metastases
- unexpected metastatic sites
But both tracers are far superior to older octreotide scans.
4. Availability
68Ga‑DOTATATE is currently more widely available. 64Cu‑DOTATATE is expanding but not yet universal.
5. Radiation
Both scans use similar, safe levels of radiation. There is no meaningful difference for patients.
🌈 Bottom line for patients
- Both scans are excellent for NET imaging.
- 64Cu‑DOTATATE offers sharper images, more flexible timing, and may detect additional small lesions.
- 68Ga‑DOTATATE is widely available, fast, and already a gold‑standard option.
- Your care team will choose the tracer that is best for your situation and available locally.
References showing how 64Cu-Dotatate compares with other SSTR PET/CTs? Click the blue links to read.
1. vs. 68Ga DOTATATE
There is a comparison of sorts between 64Cu Dotatate and 68Ga dotatate in this reference –
2. vs. 68Ga DOTATOC
Other Reads



Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Thanks for reading.
Ronny
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Neuroendocrine Cancer – normally slow but always sneaky – an awareness post from Ronny AllanOctober 30, 2017Awareness
Neuroendocrine Tumours (NETs) – Vitamin D (Cholecalciferol / Ergocalciferol)March 17, 2026Diet and Nutrition
Clinical Trials – Targeted Alpha-Emitter PRRT RYZ101/RYZ401September 14, 2022Clinical Trials and Research
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient AdvocacyDiscover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.










This is awesome Ronnie! Where do you find this stuff? I really appreciate all the research you do for us NETS!
I have lots of alerts set up and also from twitter! It’s hard work though! And thanks for sharing.